Related references
Note: Only part of the references are listed.The Reactome pathway Knowledgebase
Antonio Fabregat et al.
NUCLEIC ACIDS RESEARCH (2016)
Predicting target proteins for drug candidate compounds based on drug-induced gene expression data in a chemical structure-independent manner
Yoshiyuki Hizukuri et al.
BMC MEDICAL GENOMICS (2015)
Compound signature detection on LINCS L1000 big data
Chenglin Liu et al.
MOLECULAR BIOSYSTEMS (2015)
Open TG-GATEs: a large-scale toxicogenomics database
Yoshinobu Igarashi et al.
NUCLEIC ACIDS RESEARCH (2015)
Relating Chemical Structure to Cellular Response: An Integrative Analysis of Gene Expression, Bioactivity, and Structural Data Across 11,000 Compounds
B. Chen et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2015)
Probabilistic drug connectivity mapping
Juuso A. Parkkinen et al.
BMC BIOINFORMATICS (2014)
Novel Drug Candidates for the Treatment of Metastatic Colorectal Cancer through Global Inverse Gene-Expression Profiling
Vera van Noort et al.
CANCER RESEARCH (2014)
LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures
Qiaonan Duan et al.
NUCLEIC ACIDS RESEARCH (2014)
Rosiglitazone Inhibits Hepatic Insulin Resistance Induced by Chronic Pancreatitis and IKK-β/NF-κB Expression in Liver
Xiaolei Zhou et al.
PANCREAS (2014)
Systematic evaluation of connectivity map for disease indications
Jie Cheng et al.
GENOME MEDICINE (2014)
KCF-S: KEGG Chemical Function and Substructure for improved interpretability and prediction in chemical bioinformatics
Masaaki Kotera et al.
BMC SYSTEMS BIOLOGY (2013)
Identification of drug candidate against prostate cancer from the aspect of somatic cell reprogramming
Takeo Kosaka et al.
CANCER SCIENCE (2013)
Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding
Murat Iskar et al.
MOLECULAR SYSTEMS BIOLOGY (2013)
Challenges and opportunities of drug repositioning.
Natalia Novac
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity
Kejian Wang et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Relating drug-protein interaction network with drug side effects
Sayaka Mizutani et al.
BIOINFORMATICS (2012)
Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery
Feng Zhu et al.
NUCLEIC ACIDS RESEARCH (2012)
ChEMBL: a large-scale bioactivity database for drug discovery
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2012)
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Craig Knox et al.
NUCLEIC ACIDS RESEARCH (2011)
Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods
Shih-Fang Lin et al.
ARTIFICIAL INTELLIGENCE IN MEDICINE (2010)
KEGG for representation and analysis of molecular networks involving diseases and drugs
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2010)
Discovery of drug mode of action and drug repositioning from transcriptional responses
Francesco Iorio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Drug-Induced Regulation of Target Expression
Murat Iskar et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Identifying Network of Drug Mode of Action by Gene Expression Profiling
Francesco Iorio et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
ChemBank: a small-molecule screening and cheminformatics resource database
Kathleen Petri Seiler et al.
NUCLEIC ACIDS RESEARCH (2008)
SuperTarget and Matador: resources for exploring drug-target relationships
Stefan Guenther et al.
NUCLEIC ACIDS RESEARCH (2008)
NCBI GEO: mining tens of millions of expression profiles - database and tools update
Tanya Barrett et al.
NUCLEIC ACIDS RESEARCH (2007)
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
Tiqing Liu et al.
NUCLEIC ACIDS RESEARCH (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
A method for high-throughput gene expression signature analysis
David Peck et al.
GENOME BIOLOGY (2006)
In vitro safety pharmacology profiling:: an essential tool for successful drug development
S Whitebread et al.
DRUG DISCOVERY TODAY (2005)
Amlexanox for the treatment of recurrent aphthous ulcers
J Bell
CLINICAL DRUG INVESTIGATION (2005)
Thalidomide as an immunotherapeutic agent: The effects on neutrophil-mediated inflammation
K Yasui et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
DEG: a database of essential genes
R Zhang et al.
NUCLEIC ACIDS RESEARCH (2004)
Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats
AA Bosco et al.
DIABETOLOGIA (2003)
IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera
M Ferrer et al.
ALLERGY (2003)
Molecular mechanisms of G0/G1 cell-cycle arrest and apoptosis induced by terfenadine in human cancer cells
JD Liu et al.
MOLECULAR CARCINOGENESIS (2003)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
The multiplicity of serotonin receptors: Uselessly diverse molecules or an embarrassment of riches?
BL Roth et al.
NEUROSCIENTIST (2000)
Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists
U Lippert et al.
EXPERIMENTAL DERMATOLOGY (2000)
Share Paper
